Methionine

Amino Acid / Urinary Acidifier Sulfur-containing essential amino acid

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 200-300 mg/kg/day divided q8-12h (for urine acidification) q8-12h Duration: Variable; often 2-4 weeks for struvite dissolution, then reassess
Notes: Dose should be adjusted based on urine pH monitoring (target pH 6.0-6.5). Use with a struvite dissolution diet.
Cat PO 200-300 mg/kg/day divided q8-12h (for urine acidification) q8-12h Duration: Variable; often 2-4 weeks for struvite dissolution, then reassess
Notes: Dose should be adjusted based on urine pH monitoring (target pH 6.0-6.5). Use with a struvite dissolution diet.
Horse PO Not established; may be used as a supplement at 10-20 g/day q24h Duration: Variable
Notes: Limited evidence; use with caution.
Cattle PO Not established; may be used as a supplement at 10-20 g/day q24h Duration: Variable
Notes: Limited evidence; use with caution.
Rabbit PO Not established; may be used at 100-200 mg/kg/day q12h Duration: Variable
Notes: Limited evidence; use with caution.

Clinical Indications & Species Uses

General Indications
  • Urinary acidification for the prevention and dissolution of struvite uroliths in small animals
  • Adjunct in the management of urinary tract infections where urine acidification is beneficial
  • Dietary supplement for sulfur amino acid deficiency
Dog (Canine)
  • Prevention and dissolution of struvite uroliths (with appropriate diet and management)
  • Urinary acidification in the management of certain urinary tract infections (e.g., to enhance efficacy of antibiotics like methenamine)
  • Adjunct in the management of feline lower urinary tract disease (FLUTD) when urine acidification is desired
  • Supportive therapy for hepatic conditions (as a precursor to SAMe)
Cat (Feline)
  • Prevention and dissolution of struvite uroliths (with appropriate diet and management)
  • Urinary acidification in the management of feline lower urinary tract disease (FLUTD)
  • Adjunct in the management of urinary tract infections when urine acidification is beneficial

Pharmacology & Mechanism of Action

Drug Class: Amino Acid / Urinary Acidifier | Pharmacological Group: Sulfur-containing essential amino acid

Mechanism of Action: Methionine is an essential sulfur-containing amino acid that serves as a precursor for cysteine, taurine, and glutathione. In veterinary medicine, it is primarily used as a urinary acidifier. Methionine is metabolized to sulfate and hydrogen ions, which are excreted in the urine, thereby lowering urine pH. The acidifying effect is dose-dependent and helps to dissolve struvite (magnesium ammonium phosphate) crystals and prevent their formation in dogs and cats. Additionally, methionine acts as a methyl donor in various biochemical pathways and is involved in protein synthesis and detoxification processes.

Pharmacodynamics: Methionine's primary pharmacodynamic effect in veterinary use is the reduction of urine pH. It is metabolized to sulfuric acid, which is excreted in the urine, leading to a decrease in urinary pH. This acidification enhances the solubility of struvite crystals and may also reduce the risk of calcium oxalate stone formation in some cases, although its use is more commonly associated with struvite management. Methionine also has antioxidant properties through its role as a precursor to glutathione, and it supports hepatic function by promoting the synthesis of S-adenosylmethionine (SAMe), which is involved in methylation reactions and antioxidant defense.

⚑ Pharmacokinetics Summary

Absorption: Methionine is readily absorbed from the gastrointestinal tract via active transport mechanisms. Oral absorption is efficient, with peak plasma concentrations occurring within 1-2 hours after administration. Bioavailability is high, though it may be reduced in the presence of certain dietary components or gastrointestinal disease.
Distribution: Methionine is widely distributed throughout the body, crossing the blood-brain barrier and placental barrier. It is taken up by tissues, particularly the liver, where it is metabolized. It is also distributed into milk and may be present in eggs in laying birds.
Metabolism: Methionine is extensively metabolized in the liver. The primary metabolic pathways include conversion to S-adenosylmethionine (SAMe), which serves as a methyl donor, and transsulfuration to cysteine, which can be further metabolized to sulfate and taurine. The sulfate is excreted in the urine, contributing to the acidifying effect.
Excretion: Methionine is primarily excreted in the urine as sulfate and other metabolites. A small fraction is excreted unchanged. The renal excretion of sulfate and hydrogen ions is responsible for the urine acidification. In animals with renal impairment, excretion may be reduced, leading to accumulation and potential toxicity.
Half-Life: The half-life of methionine in dogs is approximately 1-2 hours, but the acidifying effect on urine pH may last for 6-12 hours depending on the dose and formulation. In cats, the half-life is similar, but the duration of urine acidification may be shorter.
Bioavailability: Oral bioavailability is high, estimated at 80-100% in dogs and cats, though it may be reduced by the presence of food or gastrointestinal disease.
Protein Binding: Methionine is not significantly bound to plasma proteins; it exists primarily in free form in the plasma.

Available Formulations & Strengths

Oral Tablet 200 mg, 500 mg (PO)
Oral Capsule 200 mg, 500 mg (PO)
Oral Powder Various (e.g., 100 g, 500 g) (PO)
Oral Solution Various (e.g., 100 mg/mL) (PO)

Contraindications & Clinical Warnings

Contraindications:
  • Hypersensitivity to methionine or any component of the formulation
  • Severe hepatic insufficiency (may worsen encephalopathy)
  • Severe renal insufficiency (may cause metabolic acidosis)
  • Use in animals with pre-existing metabolic acidosis
  • Use in animals with urate or cystine uroliths (acidification may promote these stones)
Warnings & Clinical Precautions:
  • Use with caution in animals with hepatic disease, as methionine may precipitate hepatic encephalopathy.
  • Use with caution in animals with renal disease, as acidification may worsen acidosis.
  • Monitor urine pH regularly to avoid over-acidification (urine pH < 6.0 may increase risk of calcium oxalate stones).
  • Use with caution in pregnant or lactating animals; safety not established.
  • Do not use in animals with a history of pancreatitis or gastrointestinal ulceration.
  • May interfere with urine tests for ketones or other analytes.

Adverse Effects & Reactions

Common:

  • Gastrointestinal upset (vomiting, diarrhea, anorexia)
  • Decreased appetite
  • Changes in urine pH (over-acidification)

Serious / Severe:

  • Metabolic acidosis (especially with overdose or renal impairment)
  • Hepatic encephalopathy in animals with liver disease
  • Hemolytic anemia (rare, with high doses)
  • Hyperammonemia (in animals with urea cycle disorders)

Rare:

  • Allergic reactions (urticaria, angioedema)
  • Thrombocytopenia
  • Crystalluria (calcium oxalate stones)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Methenamine Methionine acidifies urine, which enhances the conversion of methenamine to formaldehyde, increasing its antibacterial effect. However, this combination may increase the risk of crystalluria. Moderate
Urinary alkalinizers (e.g., sodium bicarbonate, potassium citrate) These agents counteract the acidifying effect of methionine, reducing its efficacy. Moderate
Sulfonamides Acidification may increase the risk of sulfonamide crystalluria. Moderate
NSAIDs (e.g., aspirin, carprofen) Methionine may increase the risk of gastrointestinal irritation when used with NSAIDs. Mild
Corticosteroids May increase the risk of gastrointestinal ulceration when used with methionine. Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Severe metabolic acidosis
  • Vomiting, diarrhea
  • Lethargy, weakness
  • Tachypnea (compensatory hyperventilation)
  • Ataxia, seizures (in severe cases)
  • Hepatic encephalopathy (in animals with liver disease)

Emergency Treatment Protocol: Treatment is primarily supportive. Discontinue methionine and provide symptomatic care. Administer intravenous fluids to correct dehydration and electrolyte imbalances. Sodium bicarbonate may be administered to correct metabolic acidosis, but use with caution and monitor blood gases. In severe cases, hospitalization and intensive monitoring are required. There is no specific antidote.

Food Animal Withdrawal Times

πŸ₯© Meat: 0 daysπŸ₯› Milk: 0 daysπŸ₯š Eggs: 0 days

Methionine is a naturally occurring amino acid and is generally considered to have a zero withdrawal time. However, for food animals, it is recommended to follow label instructions and consult with a veterinarian regarding any extra-label use.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (20-25Β°C, excursions permitted to 15-30Β°C).

Handling & Special Conditions: Keep container tightly closed. Protect from moisture. Store away from direct heat.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Approved for veterinary use in dogs and cats for urinary acidification. Some formulations are approved as dietary supplements.

Extra-Label (Off-Label) Use: In the US, methionine is available as an over-the-counter product for veterinary use. Extra-label use in food animals is permitted under AMDUCA with a valid veterinarian-client-patient relationship, but withdrawal times must be observed as determined by the veterinarian.

Clinical Pearls & Practice Notes

πŸ’‘ Clinical Insights: Methionine is primarily used in small animal practice as a urinary acidifier for the prevention and dissolution of struvite uroliths. It is important to monitor urine pH regularly to avoid over-acidification, which can predispose to calcium oxalate stone formation. Methionine should be used in conjunction with a appropriate therapeutic diet and increased water intake. It is not recommended for use in animals with hepatic or renal insufficiency. In food animals, its use is limited and should be based on veterinary guidance. Always consider the underlying cause of urolithiasis and address dietary and management factors.

References & Literature

  • πŸ“š Plumb's Veterinary Drug Handbook
  • πŸ“š Papich Veterinary Pharmacology and Therapeutics
  • πŸ“š Compendium of Veterinary Products (CVP)